Stockscreener 앱 받기
9.61
4.80%
0.44
시간 외 거래:
9.63
0.02
+0.21%
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
Why hedge funds are buying Ginkgo Bioworks Holdings Inc. stock2026 world cup usa national team qualification star players transition play odds analysis preview - ulpravda.ru
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks announces COO transition and operational leadership changes By Investing.com - Investing.com Australia
Ginkgo Bioworks announces COO transition and operational leadership changes - Investing.com
Is Ginkgo Bioworks Holdings Inc a good long term investmentInsider Trading Compliance & Affordable Trading Techniques - earlytimes.in
Penny Stocks That Will Make You Richcareer Html Definition Characteristics & How To Invest - shababeek.org
Ginkgo Bioworks Holdings, Inc. (DNA) rises as market takes a dip: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st
Liquidity Mapping Around (DNA) Price Events - Stock Traders Daily
Ginkgo Bioworks announces operating leadership transition effective January 2026 - Investing.com India
Ginkgo Bioworks realigns leadership, shifts COO responsibilities - MSN
Ginkgo Bioworks announces operating leadership transition effective January 2026 By Investing.com - Investing.com Australia
Ginkgo Bioworks Announces COO Transition - TradingView — Track All Markets
Ginkgo Bioworks shifts operating duties in leadership restructure - StreetInsider
Ginkgo Bioworks (NYSE: DNA) realigns leadership as Shetty refocuses on lab - Stock Titan
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - Sahm
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans - Sahm
Ginkgo Bioworks, Carnegie Mellon Partner on At-Home Cancer Detection Technology - marketscreener.com
Ginkgo Bioworks partners with CMU on innovative cancer detection By Investing.com - Investing.com Canada
Ginkgo Bioworks (NYSE:DNA) Trading Up 10%Time to Buy? - MarketBeat
How rising interest rates impact Ginkgo Bioworks Holdings Inc. stock2025 Historical Comparison & Weekly Chart Analysis and Guides - bolumsonucanavari.com
Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Is Ginkgo Bioworks Holdings Inc. stock resilient to inflationEarnings Miss & Consistent Income Trade Ideas - DonanımHaber
Is Ginkgo Bioworks Holdings Inc. stock a contrarian buy2025 Price Momentum & Weekly Top Performers Watchlists - Улправда
Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessJuly 2025 Rallies & Daily Profit Focused Stock Screening - DonanımHaber
Will Ginkgo Bioworks Holdings Inc. stock maintain momentum in 20252025 Volatility Report & Safe Capital Allocation Plans - Улправда
Ginkgo Bioworks, Agricen Collaborate on Soil Amendment Fermentation - marketscreener.com
Ginkgo Bioworks and Agricen complete fermentation process optimization By Investing.com - Investing.com Canada
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment - Finviz
New partnership speeds up production of helpful soil bacteria for crops - Stock Titan
CFO Coen Acquires 750 Of Ginkgo Bioworks Holdings Inc [DNA] - TradingView — Track All Markets
Ginkgo Bioworks Holdings, Inc. (DNA) insider details RSU vesting and tax sale - Stock Titan
DNA (NYSE: DNA) holder plans sale of 736 Class A shares on NYSE per notice - Stock Titan
Price-Driven Insight from (DNA) for Rule-Based Strategy - Stock Traders Daily
What analysts say about Ginkgo Bioworks Holdings Inc stockDividend Stability Analysis & Rapid Portfolio Gain - earlytimes.in
Ginkgo Bioworks awarded four-year, up to $47M contract from EMSL - MSN
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies - Investing News Network
Jump Financial LLC Acquires New Stake in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Treas Che Files To Sell 2,200 Of Ginkgo Bioworks Holdings Inc [DNA] - TradingView — Track All Markets
Ginkgo Bioworks (NYSE: DNA) insider files to sell 2,200 shares - Stock Titan
Recent Uptick Might Appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Institutional Owners After Losing 13% Over the Past Year - 富途牛牛
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety - Investing News Network
Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform - marketscreener.com
Ginkgo Bioworks Partners on Deep Origin-Led Team to Develop New Tools for Pred Predictive Drug Safety - marketscreener.com
Ginkgo Bioworks partners with Deep Origin on ARPA-H drug safety project - Investing.com UK
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpWhat's Next? - MarketBeat
Ginkgo Bioworks to Hold Special Meeting of Shareholders - GuruFocus
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform - Investing.com
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform By Investing.com - Investing.com South Africa
Ginkgo Bioworks Awarded 4-Year Energy Department Contract Valued at Up to $47 Million - marketscreener.com
28.63%
자본화:
|
볼륨(24시간):